Subscribe
shutterstock_1179311575_vchal
Vchal / Shutterstock.com
30 September 2019AmericasSarah Morgan

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Personal Genomics takes PacBio dispute to Chinese court
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Americas
Illumina buys rival Pacific Biosciences for $1.2bn
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Asia
Personal Genomics takes PacBio dispute to Chinese court
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Americas
Illumina buys rival Pacific Biosciences for $1.2bn
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.

More on this story

Asia
Personal Genomics takes PacBio dispute to Chinese court
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Americas
Illumina buys rival Pacific Biosciences for $1.2bn
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler